R
Roberto Pontarolo
Researcher at Federal University of Paraná
Publications - 314
Citations - 4799
Roberto Pontarolo is an academic researcher from Federal University of Paraná. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 28, co-authored 283 publications receiving 3474 citations. Previous affiliations of Roberto Pontarolo include Federal University of Pará.
Papers
More filters
Journal ArticleDOI
Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19.
Beatriz Böger,Mariana Millan Fachi,Raquel de Oliveira Vilhena,Alexandre de Fátima Cobre,Fernanda S. Tonin,Roberto Pontarolo +5 more
TL;DR: RT-PCR remains the gold standard for the diagnosis of COVID-19 in sputum samples and the combination of different diagnostic tests is highly recommended to achieve adequate sensitivity and specificity.
Journal ArticleDOI
Network meta-analysis: a technique to gather evidence from direct and indirect comparisons.
TL;DR: A basic explanation of network meta-analysis conduction is provided, highlighting its risks and benefits for evidence-based practice, including information on statistical methods evolution, assumptions and steps for performing the analysis.
Journal ArticleDOI
Ethnobotanical and scientific aspects of malva sylvestris l.: a millennial herbal medicine
João Cleverson Gasparetto,Cleverson Antonio Ferreira Martins,Sirlei Sayomi Hayashi,Michel Fleith Otuky,Michel Fleith Otuky,Roberto Pontarolo +5 more
TL;DR: An anti‐ulcerogenic effect was recently proven, demonstrating that the aqueous extract of Malva sylvestris L. was more effective than cimetidine, a potent medicine used to treat gastric ulcers.
Journal ArticleDOI
Impact of Neonatal Screening and Surveillance for the TP53 R337H Mutation on Early Detection of Childhood Adrenocortical Tumors
Gislaine Custódio,Guilherme A Parise,Nilton Kiesel Filho,Heloisa Komechen,Cesar Cavalli Sabbaga,Roberto Rosati,Leila Grisa,Ivy Zortéa S Parise,Mara Albonei Dudeque Pianovski,Carmem M.C.M. Fiori,Jorge Alberto Ledesma,José Renato S. Barbosa,Francisco R.O. Figueiredo,Elis R. Sade,Humberto C. Ibañez,Sohaila B.I. Arram,Sérvio Túlio Stinghen,Luciano R. Mengarelli,Mirna M O Figueiredo,Danilo C. Carvalho,Sylvio Gilberto Andrade Avilla,Thiago Demetrius Woiski,Lisiane de Castro Poncio,Geneci F.R. Lima,Roberto Pontarolo,Enzo Lalli,Yinmei Zhou,Gerard P. Zambetti,Raul C. Ribeiro,Bonald C. Figueiredo +29 more
TL;DR: These findings establish the prevalence of the TP53 R337H mutation in Paraná state and the penetrance of ACTs among carriers and show that screening and surveillance of heterozygous carriers are effective in detecting ACTs when readily curable.
Journal ArticleDOI
Meta-analysis of the Efficacy and Safety of Adalimumab, Etanercept, and Infliximab for the Treatment of Rheumatoid Arthritis
TL;DR: The efficacy and safety of using the anti‐tumor necrosis factor‐α (anti‐TNF‐α) drugs adalimumab, etanercept, and infliximab for the treatment of rheumatoid arthritis are evaluated.